Pneumonia, infant, pharmaceutical care, clinical services.
Abstract
Pneumonia was regarded as "the captain of the men of death" during the 19th century. It was
more dreadful illness of infants. However; the advents of antibiotic and vaccines in the 20th
century have contributed the radical improvements in survival outcomes. Nevertheless, in the
third world, and among the very old, the very young and the chronically ill, pneumonia remains a
leading cause of death. Thus; we have aimed this case study to understand the scientific and
therapeutical comprehension of pneumonia. A six month old baby (girl) was presented in a local
hospital, Rawalpindi, Pakistan with pneumonia. On basis of her medical investigation the
physician prescribed the injection Claforan (cefotaxime) 250mg IV (intra venous) TDS (three
time a day) for four days; injection Grasil (amikacin sulphate) 50mg IV BID (two time a day);
Ventolin (salbutamol albuterol) nebulisation after every 3 hours; syrup Paramac (paracetamol) 1
TSF (tea spoonful) or 120mg /5ml SOS (as required); injection Lasix (furusemide) 10mg IV stat
(immediately); tablet Capoten (captopril) 12.5mg 1⁄2 BID; syrup Acefyl (acefylline piperazine)
and syrup Phenergan were administered for first two days. Her vomiting and coughing symptoms
were settled. Vital signs showed fever of RR 38 breaths /minute, HR 110/minute, CVS= S1+S2+
Ponsystolic membrane and 102°F temperature. No cyanosis and clubbing were observed. There
were certain clinical and pharmaceutical inaccuracies were noted during the treatment. Thus; a
rational clinical practice needed to implement health care system. Specially; the avoidable
clinical errors are required to be addressed to optimize the regimens. Moreover; the substandard
pharmaceutical care and poor clinical services are major obstacles to cure this disease. Therefore;
the comprehensive clinical examination and therapeutical care will help to avoid the undesired
health related consequences.